Diabetes

Top Story

NIH funds trial of chelation therapy for patients with diabetes, prior MI

NIH funds trial of chelation therapy for patients with diabetes, prior MI
September 28, 2016

Mount Sinai Medical Center of Florida announced that it and Duke Clinical Research Institute have received an NIH grant of $37 million to fund a second study of IV chelation therapy in patients with prior MI.

The trial, TACT2, aims to determine whether IV chelation treatments plus oral vitamins prevent recurrent CV events such as MI, stroke and CV death in patients with diabetes aged 50 years or older, according to a press release issued by Mount Sinai.

In the Journals

Statin use low for many patients with diabetes at risk for CVD

September 12, 2016
Prescriptions for statin therapy that could lower risk for MI, stroke and mortality were not written for patients with diabetes considered high risk for CVD in nearly…
In the Journals

Coronary CTA provides valuable CAD risk stratification in patients with diabetes

September 12, 2016
Patients with diabetes with nonobstructive and obstructive CAD according to coronary CTA are at higher risk for all-cause mortality and major adverse cardiac events at 5…
In the Journals

Internet, mobile devices can improve healthy lifestyle choices

September 9, 2016
According to a systematic review published in the Journal of the American Heart Association, people who are prompted by cellphones and other devices are more likely to…
Cover Story

Beyond safety, new diabetes drugs offer CV benefit

Cardiology Today, September 2016
The medical community has long recognized the strong relationship between CVD and diabetes. Compounding concerns over…
More »
Video
Meeting News Coverage

VIDEO: Positive CV outcomes with SGLT2 inhibitors mark ‘an exciting time’

January 7, 2016
More »
Video
Meeting News Coverage

VIDEO: Diabetes may be risk equivalent for PAD, CAS

April 3, 2016
More »
In the Journals

Arterial revascularization benefits patients with diabetes undergoing CABG

July 15, 2016
CABG with total arterial revascularization conferred better long-term mortality in patients with diabetes than conventional CABG, researchers…

In the Journals

NHANES: HbA1c increasing among adults with obesity

July 14, 2016
Adults with obesity have experienced a steady increase in mean HbA1c during the past 3 decades, which indicates a rising risk for type 2 diabetes…

In the Journals

Diabetes increases mortality risk after acute MI

July 5, 2016
Adults with diabetes have higher mortality risk after an acute MI than those without diabetes, according to data published in the Journal of

Meeting News CoverageVideo

VIDEO: Results of LEADER trial provide “robust demonstration” of cardiovascular event reduction in high-risk type 2 diabetes

July 1, 2016
NEW ORLEANS — In this video, Michael T. McDermott, MD, director of endocrinology and diabetes practice at the University of Colorado Hospital…

FDA NewsPerspective

FDA advisory committee splits on CV benefit claim for Jardiance

June 28, 2016
An FDA advisory panel on Tuesday voted 12 to 11 in favor of an expanded indication for the SGLT2 inhibitor Jardiance, supporting language in the…

Meeting News Coverage

Actos reduces type 2 diabetes risk in adults with prediabetes, prior stroke

June 16, 2016
NEW ORLEANS — The risk for developing type 2 diabetes, especially among those with prediabetes and/or who have had strokes may be reduced with…

FDA News

FDA strengthens kidney warnings on Invokana, Farxiga labels

June 14, 2016
The FDA issued a drug safety communication stating that it has revised the warning labels of SGLT2 inhibitors Invokana/Invokamet and Farxiga/Xigduo…

Meeting News CoveragePerspective

Jardiance slows kidney disease progression in adults with type 2 diabetes

June 14, 2016
NEW ORLEANS — The SGLT2 inhibitor Jardiance was associated with slower progression of kidney disease and fewer clinically relevant renal events…

Meeting News Coverage

Diabetes Collaborative Registry highlights real-world clinical management of patients with diabetes

June 14, 2016
NEW ORLEANS — Clinicians who submit data to the Diabetes Collaborative Registry regularly adhere to four of seven quality metrics when treating…

Meeting News CoveragePerspective

LEADER trial: Victoza lowers risk for CV death, MI, stroke in high-risk type 2 diabetes

June 13, 2016
NEW ORLEANS — Patients with type 2 diabetes and a history of cardiovascular disease assigned Victoza therapy saw reduced risk for…

More Headlines »
morganatic-roan
morganatic-roan